Science Explorer Interactive view Map
Topic · Pathology and Forensic Medicine

Chemotherapy-induced organ toxicity mitigation

Chemotherapy-induced organ toxicity mitigation is a research topic within Pathology and Forensic Medicine. Science Explorer counts 11k research works in it since 1950. 21.7% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the mechanisms of cisplatin-induced nephrotoxicity, including oxidative stress, apoptosis, inflammation, and mitochondrial dysfunction. It also explores various renoprotective strategies and potential interventions to mitigate kidney injury caused by cisplatin. The research covers a wide range of topics such as the role of specific antioxidants, inflammatory pathways, and cellular mechanisms involved in chemotherapy-induced kidney damage.

  • Cisplatin
  • Nephrotoxicity
  • Renoprotective Strategies
  • Oxidative Stress
  • Apoptosis
  • Inflammation
  • Mitochondrial Dysfunction
  • Antioxidants
  • Chemotherapy
  • Kidney Injury
Research works
11k
fractional, since 1950
In the world top 10%
2.4k
per year above
Top-10% rate
21.7%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+24%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Chemotherapy-induced organ toxicity mitigation research?

By volume, China and the United States publish the most (423 and 228 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 423 works
  2. 2 United States 228 works
  3. 3 Egypt 192 works
  4. 4 Türkiye 157 works
  5. 5 India 139 works
  6. 6 Iran 134 works
  7. 7 Japan 110 works
  8. 8 Saudi Arabia 76 works
  9. 9 Iraq 50 works
  10. 10 South Korea 40 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 27.3%United States: 14.7%Egypt: 12.4%Türkiye: 10.1%6 others listed: 35.4%27%largest
China423 · 27.3%United States228 · 14.7%Egypt192 · 12.4%Türkiye157 · 10.1%6 others listed548 · 35.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Chemotherapy-induced organ toxicity mitigation research?

By volume in 2022–2025, Mansoura University publishes the most Chemotherapy-induced organ toxicity mitigation research, followed by Cairo University and Zagazig University.

By volume, 2022–2025

  1. 1 Mansoura UniversityEgypt 20 works
  2. 2 Cairo UniversityEgypt 18 works
  3. 3 Zagazig UniversityEgypt 14 works
  4. 4 Tanta UniversityEgypt 13 works
  5. 5 Mashhad University of Medical SciencesIran 11 works
  6. 6 King Saud UniversitySaudi Arabia 10 works
  7. 7 National Research CentreEgypt 10 works
  8. 8 Al-Azhar UniversityEgypt 10 works
  9. 9 Alexandria UniversityEgypt 10 works
  10. 10 Ain Shams UniversityEgypt 9 works

Where is Chemotherapy-induced organ toxicity mitigation research done?

The largest centres of Chemotherapy-induced organ toxicity mitigation research in 2022–2025 are Cairo (Egypt), Beijing (China), Guangzhou (China) and Giza (Egypt). Among places with at least 20 works in it, it is an unusually large share of all research in Al Mansurah.

Largest cities, 2022–2025

  1. 1 Cairo Egypt 43 works
  2. 2 Beijing China 40 works
  3. 3 Guangzhou China 34 works
  4. 4 Giza Egypt 31 works
  5. 5 Tehran Iran 29 works
  6. 6 Tokyo Japan 28 works
  7. 7 Riyadh Saudi Arabia 26 works
  8. 8 Shanghai China 25 works
  9. 9 Nanjing China 23 works
  10. 10 Al Mansurah Egypt 22 works

Where it is the local speciality

  1. Al MansurahEG · 21.8 works21×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Chemotherapy-induced organ toxicity mitigation than the world average.

See Chemotherapy-induced organ toxicity mitigation on the map

Where is the best place to study Chemotherapy-induced organ toxicity mitigation?

Among universities, judged by research, Cairo University, Al-Azhar University and Mansoura University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%60%mean 31.54%fractional works in this node (log) →share in the world top 10% →Cairo University: 18, 36.7%Al-Azhar University: 10, 42.7%Mansoura University: 20, 29.2%Beni-Suef University: 8, 38.0%Zagazig University: 14, 15.5%Atatürk University: 8, 54.2%Tanta University: 13, 23.0%Mashhad University of Medical Sciences: 11, 20.5%Alexandria University: 10, 10.2%King Saud University: 10, 45.4%Al-Azhar UniversityBeni-Suef UniversityCairo UniversityMansoura University
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Cairo UniversityEgypt 73.736.7%11.5×18 +115.4%
2 Al-Azhar UniversityEgypt 72.342.7%12.5×10 +256.9%
3 Mansoura UniversityEgypt 70.129.2%21.2×20 +96.6%
4 Beni-Suef UniversityEgypt 63.638.0%25.0×8 +184.0%
5 Zagazig UniversityEgypt 61.015.5%18.9×14 +211.2%
6 Atatürk UniversityTürkiye 59.754.2%11.1×8 +61.7%
7 Tanta UniversityEgypt 57.223.0%21.0×13 +107.1%
8 Mashhad University of Medical SciencesIran 48.620.5%23.7×11 +98.6%
9 Alexandria UniversityEgypt 48.510.2%10.2×10 +317.7%
10 King Saud UniversitySaudi Arabia 39.045.4%5.5×10 -0.7%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Chemotherapy-induced organ toxicity mitigation research growing?

Output in 2018–2022 was 24% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Chemotherapy-induced organ toxicity mitigation.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.